MRAAY(MRAAY)
MRAAY
No analyst ratings available
No analyst price targets available for MRAAY
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $1.99T | $2.35T |
| Low | $1.85T | $2.19T |
| High | $2.14T | $2.53T |
| EBITDA Avg | $560.07B | $660.92B |
| Low | $520.72B | $614.48B |
| High | $601.83B | $710.20B |
| EBIT Avg | $364.46B | $430.08B |
| Low | $338.85B | $399.86B |
| High | $391.63B | $462.15B |
| Net Income Avg | $323.18B | $522.97B |
| Low | $293.66B | $475.20B |
| High | $354.51B | $573.66B |
| EPS Avg | $88.18 | $142.69 |
| Low | $80.13 | $129.66 |
| High | $96.73 | $156.52 |
| Analysts (Rev / EPS) | 9 / 1 | 9 / 1 |
| Metric | Q3 2026 |
|---|---|
| Revenue Avg | $500.22B |
| Low | $479.08B |
| High | $524.07B |
| EBITDA Avg | $140.47B |
| Low | $134.53B |
| High | $147.16B |
| EBIT Avg | $91.41B |
| Low | $87.54B |
| High | $95.76B |
| Net Income Avg | $81.99B |
| Low | $77.49B |
| High | $87.08B |
| EPS Avg | $22.45 |
| Low | $21.21 |
| High | $23.84 |
| Analysts (Rev / EPS) | 3 / 1 |